Advanced
Process Development

for NOVEL BIOTHERAPEUTICS //
VIRAL VECTORS, BIONANOPARTICLES, BIOLOGICS

Smarter processes. Faster results.
We optimize your bioproduction from lab to clinic — cutting cost, time, and risk along the way.

Expertise

Your premier partner for advanced process development // vaccines, immuno-oncology, cell & gene therapy

Our production processes enable you to bring your biotherapeutics to patients — efficiently, reliably, and at scale to meet today’s most urgent medical needs.

Our production processes enable you to bring your biotherapeutics to patients — efficiently, reliably, and at scale to meet today’s most urgent medical needs.

Approach

Our approach is your advantage

Effective development is paramount for optimizing process efficiency, robustness, scalability, and product quality.

bespark*bio’s advanced process development solutions combine best-in-class bioprocessing expertise and state-of the-art technology with contemporary digitalization and machine-learning approaches.

Modular building blocks and pre-established framework technologies reduce complexity and offer adaptable resources that serve as launch pad for process customization.

The result: faster timelines, lower costs, deeper process insight, and reduced failure risk.

Services

What we offer: first time right!

CMC
Strategies

Our tailored CMC strategies and roadmaps guide you through every
stage of development.

Production
Processes

Operating within our state-of the-art facility, we design, develop and optimize phase-appropriate, robust and scalable production
processes.

Process
Analytics

We develop and integrate tailored analytical methods to track progress of development activities.

GMP
Support

Our GMP support guarantees seamless transition to GMP production, fostering efficiency and compliance throughout.
Free Assessment

Is Your Team Ready for CMC Development?

Are These CMC Challenges Keeping You Awake at Night?

Uncertain if your expression system will scale

Analytical methods that fail during tech transfer

Regulatory strategy gaps that could delay your IND filing

CDMO selection – too many options, unclear criteria

Quality systems that aren’t ready for GMP requirements

Budget uncertainty for CMC development phases

Get Crystal Clear on Your CMC Readiness in Just 3 Minutes

Answer 13 questions and you’ll get personalized advice to accelerate your path to clinical trials.

Personalized Assessment: Tailored to your product type and development stage

Gap Analysis: Identify exactly where you need to focus first

Action Plan: Get specific next steps to accelerate progress

Start Your Free Assessment

News

Insights

February 16.2026 //

SALT’N’VENTURE | March 11-12!

bespark*bio has been selected to pitch at Salt’N’Venture, a startup and investment conference bringing together founders, investors and industry leaders to spotlight scalable innovation.

We will present in the Human Tech Track, which features technologies advancing healthcare and life sciences with real-world impact.

Our participation at Salt’N’Venture marks an important step in positioning bespark*bio as a highly specialized, scalable enabler within the biopharmaceutical value chain.
January 23.2026 //

bespark*bio goes SEOUL | 15-19 June 2026!

bespark*bio has been selected for GO SEOUL 2026, a market access program connecting innovative companies with Korean clients, partners, investors, and industry networks.

Korea’s biotech ecosystem is scaling at impressive speed, with strong momentum in advanced therapeutics and biomanufacturing innovation. 

We bring a proven, data-driven bioprocessing approach that helps translate cutting-edge therapeutics into robust, scalable, and cost-efficient manufacturing processes – faster and with reduced risk.

A perfect match!
Voices

What Our Clients Say

p4b

‘A development partner who understands tech-driven scale-up’

bespark*bio was among the first to put our technology through real-world testing – and they did so with technical excellence and strategic thinking.

loop lab

‘A critical thinking partner in CMC’

bespark*bio didn’t offer off-the-shelf answers; they helped us shape a strategy tailored to our stage, our risks, and our ambitions.

CELLREV

‘A forward-thinking and collaborative partnership’

Partnering with bespark*bio was a seamless extension of our innovation-driven work, providing
CellRev value beyond standard subcontracting in a complex “black box” field.

Biomay

‘A Snapshot of Executional Excellence’

We brought them in to explore performance of our AAV platform – what we got was fast, focused, and scientifically sound execution.